What was old is new again: using the host response to diagnose infectious disease. (Q30376327)

21 June 2017

1 reference

title

What was old is new again: using the host response to diagnose infectious disease. (English)

1 reference

21 June 2017

Emily R Ko

1

1 reference

21 June 2017

William E Yang

2

1 reference

21 June 2017

Micah T McClain

3

1 reference

21 June 2017

Christopher W Woods

4

1 reference

21 June 2017

Geoffrey S Ginsburg

5

1 reference

21 June 2017

Ephraim L Tsalik

6

1 reference

21 June 2017

publication date

4 July 2015

1 reference

Expert Review of Molecular Diagnostics: new diagnostic technologies are set to revolutionise healthcare

21 June 2017

published in

1 reference

21 June 2017

volume

15

1 reference

21 June 2017

issue

9

1 reference

21 June 2017

page(s)

1143-1158

1 reference

History of human parasitology

21 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

SEROLOGICAL REACTIONS IN PNEUMONIA WITH A NON-PROTEIN SOMATIC FRACTION OF PNEUMOCOCCUS

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Diagnosing periprosthetic joint infection: has the era of the biomarker arrived?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Diagnostic accuracy and clinical role of rapid C-reactive protein testing in HIV-infected individuals with presumed tuberculosis in South Africa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

A blueprint for a sepsis protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Serum lactate as a predictor of mortality in patients with infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Performance of severity of illness scoring systems in emergency department patients with infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Serum lactate is associated with mortality in severe sepsis independent of organ failure and shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Disease progression in hemodynamically stable patients presenting to the emergency department with sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Rude unhinging of the machinery of life: metabolic approaches to hemorrhagic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Impaired mitochondrial function induced by serum from septic shock patients is attenuated by inhibition of nitric oxide synthase and poly(ADP-ribose) synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

A prospective, multicenter derivation of a biomarker panel to assess risk of organ dysfunction, shock, and death in emergency department patients with suspected sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Early lactate clearance is associated with improved outcome in severe sepsis and septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Multicenter study of early lactate clearance as a determinant of survival in patients with presumed sepsis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Procalcitonin: a valuable indicator of infection in a medical ICU?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Usefulness of procalcitonin for diagnosis of sepsis in the intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Serum procalcitonin for the early recognition of nosocomial infection in the critically ill patients: a preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Procalcitonin in patients undergoing cardiopulmonary bypass in open heart surgery-first results of the Procalcitonin in Heart Surgery study (ProHearts).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Procalcitonin, and cytokines document a dynamic inflammatory state in non-infected cirrhotic patients with ascites

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Effect of classic heatstroke on serum procalcitonin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Evolution and significance of circulating procalcitonin levels compared with IL-6, TNF alpha and endotoxin levels early after thermal injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Neutrophil CD64 as a diagnostic marker of sepsis: impact on neonatal care

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Circulating soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) as diagnostic and prognostic marker in neonatal sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Can sTREM-1 predict septic shock & death in late-onset neonatal sepsis? A pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

sTREM-1 predicts intensive care unit and 28-day mortality in cancer patients with severe sepsis and septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

The plasma level of soluble urokinase receptor is elevated in patients with Streptococcus pneumoniae bacteraemia and predicts mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Circulating soluble urokinase plasminogen activator receptor is stably elevated during the first week of treatment in the intensive care unit and predicts mortality in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Biomarkers of sepsis and their potential value in diagnosis, prognosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

The utility of proadrenomedullin and procalcitonin in comparison to C-reactive protein as predictors of sepsis and bloodstream infections in critically ill patients with cancer*.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Proadrenomedullin as a prognostic marker in neonatal sepsis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Diagnostic and prognostic value of presepsin in the management of sepsis in the emergency department: a multicenter prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Evaluation of soluble CD14 subtype (presepsin) in burn sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Presepsin (soluble CD14 subtype) and procalcitonin levels for mortality prediction in sepsis: data from the Albumin Italian Outcome Sepsis trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

A multibiomarker-based outcome risk stratification model for adult septic shock*.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

A biomarker panel (Bioscore) incorporating monocytic surface and soluble TREM-1 has high discriminative value for ventilator-associated pneumonia: a prospective observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Diagnostic value and prognostic evaluation of Presepsin for sepsis in an emergency department

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Cytokine markers as predictors of type of respiratory infection in patients during the influenza season.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Diagnostic accuracy of pulmonary host inflammatory mediators in the exclusion of ventilator-acquired pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

How integration of global omics-data could help preparing for pandemics - a scent of influenza.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Advancing the portfolio of tuberculosis diagnostics, drugs, biomarkers, and vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Significance of interleukin-6 (IL-6) and C-reactive protein (CRP) in children and young adults with febrile neutropenia during chemotherapy for cancer: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Computational strategies for analyzing data in gene expression microarray experiments

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Bayesian inference of the number of factors in gene-expression analysis: application to human virus challenge studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Stable feature selection for biomarker discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Detection of viruses via statistical gene expression analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Predicting Viral Infection From High-Dimensional Biomarker Trajectories

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Statistical analysis principles for Omics data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

High-Dimensional Longitudinal Genomic Data: An analysis used for monitoring viral infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Unsupervised Bayesian linear unmixing of gene expression microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Dusp3 and Psme3 are associated with murine susceptibility to Staphylococcus aureus infection and human sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

An integrated transcriptome and expressed variant analysis of sepsis survival and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Mortality among recipients of the Merck V710 Staphylococcus aureus vaccine after postoperative S. aureus infections: an analysis of possible contributing host factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Gene expression analysis, proteomics, and network discovery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Development and validation of a novel molecular biomarker diagnostic test for the early detection of sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Blood gene expression signatures predict invasive candidiasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Gene expression-based classifiers identify Staphylococcus aureus infection in mice and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Development of a novel preclinical model of pneumococcal pneumonia in nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Gene expression patterns in blood leukocytes discriminate patients with acute infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Gene expression signatures diagnose influenza and other symptomatic respiratory viral infections in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

A distinct influenza infection signature in the blood transcriptome of patients with severe community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

MicroRNAs: genomics, biogenesis, mechanism, and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Discovery of functional elements in 12 Drosophila genomes using evolutionary signatures

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Serum microRNAs are promising novel biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Circulating microRNAs as stable blood-based markers for cancer detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Microarray analysis of microRNA expression in peripheral blood mononuclear cells of critically ill patients with influenza A (H1N1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

microRNAs in circulation are altered in response to influenza A virus infection in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Comprehensive characterization of serum microRNA profile in response to the emerging avian influenza A (H7N9) virus infection in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Molecular profiling of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Methods for gene expression profiling in clinical trials of adjuvant breast cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

On-chip, real-time, single-copy polymerase chain reaction in picoliter droplets

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

On-chip single-copy real-time reverse-transcription PCR in isolated picoliter droplets

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Sensitivity and specificity of the Streptococcus pneumoniae urinary antigen test for unconcentrated urine from adult patients with pneumonia: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

The human plasma proteome: history, character, and diagnostic prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

The human plasma proteome: a nonredundant list developed by combination of four separate sources

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Proteomic technologies for the identification of disease biomarkers in serum: advances and challenges ahead

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Depletion of abundant plasma proteins and limitations of plasma proteomics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Enhanced detection of low abundance human plasma proteins using a tandem IgY12-SuperMix immunoaffinity separation strategy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Equalizer technology--Equal rights for disparate beads

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Utilizing spectral counting to quantitatively characterize tandem removal of abundant proteins (TRAP) in human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Additions to the Human Plasma Proteome via a Tandem MARS Depletion iTRAQ-Based Workflow

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Recent advances of protein microarrays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Aptamer-based biosensor arrays for detection and quantification of biological macromolecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

A novel host-proteome signature for distinguishing between acute bacterial and viral infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Integrative "omic" analysis of experimental bacteremia identifies a metabolic signature that distinguishes human sepsis from systemic inflammatory response syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

An integrated clinico-metabolomic model improves prediction of death in sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Quantitative metabolomics of urine for rapid etiological diagnosis of urinary tract infection: evaluation of a microbial-mammalian co-metabolite as a diagnostic biomarker.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

High-Dimensional Sparse Factor Modeling: Applications in Gene Expression Genomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Functional robust support vector machines for sparse and irregular longitudinal data

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Genomic transcriptional profiling identifies a candidate blood biomarker signature for the diagnosis of septicemic melioidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Molecular classification of thyroid nodules using high-dimensionality genomic data

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Cost-effectiveness of a novel molecular test for cytologically indeterminate thyroid nodules

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Preoperative diagnosis of benign thyroid nodules with indeterminate cytology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Expanding the understanding of biases in development of clinical-grade molecular signatures: a case study in acute respiratory viral infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

The current epidemiology and clinical decisions surrounding acute respiratory infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Adult-population incidence of severe sepsis in Australian and New Zealand intensive care units.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

The epidemiology of sepsis in the United States from 1979 through 2000

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Epidemiology of sepsis in Victoria, Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Barriers to the effective treatment of sepsis: antimicrobial agents, sepsis definitions, and host-directed therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Gene-expression profiling of peripheral blood mononuclear cells in sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Prevention of severe Candida infections in nonneutropenic, high-risk, critically ill patients: a randomized, double-blind, placebo-controlled trial in patients treated by selective digestive decontamination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Determinants of mortality in non-neutropenic ICU patients with candidaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Comparison of costs, length of stay, and mortality associated with Candida glabrata and Candida albicans bloodstream infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Cost savings with implementation of PNA FISH testing for identification of Candida albicans in blood cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

A new antibiotic kills pathogens without detectable resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Early goal-directed therapy in the treatment of severe sepsis and septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Antibiotic prescribing in ambulatory care settings for adults with colds, upper respiratory tract infections, and bronchitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Antibiotic prescribing for adults in ambulatory care in the USA, 2007-09.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Procalcitonin-guided antibiotic therapy: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Gene expression profiles in febrile children with defined viral and bacterial infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Whole blood gene expression profiles to assess pathogenesis and disease severity in infants with respiratory syncytial virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Enhanced monocyte response and decreased central memory T cells in children with invasive Staphylococcus aureus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Possible neuroprotective effects of lecithin and alpha-tocopherol alone or in combination against ischemia/reperfusion insult in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Apo2L/TRAIL: apoptosis signaling, biology, and potential for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

High IP-10 levels decrease T cell function in HIV-1-infected individuals on ART

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

A host-based RT-PCR gene expression signature to identify acute respiratory viral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

A host transcriptional signature for presymptomatic detection of infection in humans exposed to influenza H1N1 or H3N2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Presymptomatic prediction of sepsis in intensive care unit patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Plasticity of the systemic inflammatory response to acute infection during critical illness: development of the riboleukogram

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Diagnostic accuracy of the Xpert MTB/RIF assay for extrapulmonary and pulmonary tuberculosis when testing non-respiratory samples: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

New tuberculosis diagnostics and rollout

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Critical review of published microarray studies for cancer outcome and guidelines on statistical analysis and reporting

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Sarcoidosis blood transcriptome reflects lung inflammation and overlaps with tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Common patterns and disease-related signatures in tuberculosis and sarcoidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Host responses to melioidosis and tuberculosis are both dominated by interferon-mediated signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Systems approaches to studying the immune response in tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Distinct phases of blood gene expression pattern through tuberculosis treatment reflect modulation of the humoral immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

The human immune response to tuberculosis and its treatment: a view from the blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Sputum monitoring during tuberculosis treatment for predicting outcome: systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Metabolomics of Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Improved understanding of pathogenesis from protein interactions in Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

The use of functional genomics in conjunction with metabolomics for Mycobacterium tuberculosis research

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Discriminating active from latent tuberculosis in patients presenting to community clinics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Identification of diagnostic markers for tuberculosis by proteomic fingerprinting of serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Elucidating novel serum biomarkers associated with pulmonary tuberculosis treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Aptamer-based proteomic signature of intensive phase treatment response in pulmonary tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Biomarkers of inflammation, immunosuppression and stress with active disease are revealed by metabolomic profiling of tuberculosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Serum indoleamine 2,3-dioxygenase activity predicts prognosis of pulmonary tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Development of a metabolic biosignature for detection of early Lyme disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Host Gene Expression Profiling of Dengue Virus Infection in Cell Lines and Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Patterns of host genome-wide gene transcript abundance in the peripheral blood of patients with acute dengue hemorrhagic fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

Serum lactate and procalcitonin measurements in emergency room for the diagnosis and risk-stratification of patients with suspected infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1059278

10.1586/14737159.2015.1059278

21 January 2018

Identifiers

DOI

1 reference

21 June 2017

1 reference